10-Q Filing

APPLIED BIOSCIENCES CORP. CIK: 1607549 Q3 2016

Filing Information

Form Type	10-Q
Accession Number	`0001477932-17-000800`
Period End Date	20161231
Filing Date	20170215
Fiscal Year	2016
Fiscal Period	Q3
XBRL Instance	fift-20161231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 50 Income Statement 16 Cash Flow Statement 20 Stockholders Equity 9

Balance Sheet 50 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	-	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	-	USD	Point-in-time
Cash	`Cash`	-	USD	Point-in-time
Cash	`Cash`	$272.05K	USD	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash held in trust	`AssetsHeldInTrustNoncurrent`	$25.00K	USD	Point-in-time
Cash held in trust	`AssetsHeldInTrustNoncurrent`	-	USD	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	-	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$10.00K	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	-	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$307.05K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Equity Investment	`EquityMethodInvestments`	-	USD	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Equity Investment	`EquityMethodInvestments`	$50.00K	USD	Point-in-time
TOTAL ASSETS	`Assets`	-	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	14.83M	shares	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	10.09M	shares	Point-in-time
TOTAL ASSETS	`Assets`	$357.05K	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	10.09M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	14.83M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.26K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.84K	USD	Point-in-time
Due to former CEO	`DueToFormerCeo`	$49.52K	USD	Point-in-time
Due to former CEO	`DueToFormerCeo`	-	USD	Point-in-time
Due to related party	`DueToRelatedPartiesCurrent`	$5.92K	USD	Point-in-time
Due to related party	`DueToRelatedPartiesCurrent`	$18.67K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$70.03K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$8.18K	USD	Point-in-time
Preferred stock; $0.00001 par value; 5,000,000 shares authorized; none issued and outstanding at December 31, 2016 (unaudited) and March 31, 2016	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock; $0.00001 par value; 5,000,000 shares authorized; none issued and outstanding at December 31, 2016 (unaudited) and March 31, 2016	`PreferredStockValue`	-	USD	Point-in-time
Common stock; $0.00001 par value; 200,000,000 shares authorized as of December 31, 2016 (unaudited) and March 31, 2016; 14,831,757 and 10,090,000 issued and outstanding at December 31, 2016 (unaudited) and March 31, 2016, respectively	`CommonStockValue`	$101.00	USD	Point-in-time
Common stock; $0.00001 par value; 200,000,000 shares authorized as of December 31, 2016 (unaudited) and March 31, 2016; 14,831,757 and 10,090,000 issued and outstanding at December 31, 2016 (unaudited) and March 31, 2016, respectively	`CommonStockValue`	$148.00	USD	Point-in-time
Stock Subscription Receivable	`StockholdersEquityNoteSubscriptionsReceivable`	-	USD	Point-in-time
Stock Subscription Receivable	`StockholdersEquityNoteSubscriptionsReceivable`	$101.00	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	-	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$739.95K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-8.18K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-453.09K	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquity`	$287.01K	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquity`	$-8.18K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	`LiabilitiesAndStockholdersEquity`	-	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	`LiabilitiesAndStockholdersEquity`	$357.05K	USD	Point-in-time

Income Statement 16 line items

Line Item	Tag	Value	Unit	Period
REVENUE	`Revenues`	$17.50K	USD	1 Quarter
REVENUE	`Revenues`	$17.50K	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$-54.86K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$-86.05K	USD	3 Qtrs
Reverse merger costs	`PaymentsForMergerRelatedCosts`	$376.37K	USD	3 Qtrs
Reverse merger costs	`PaymentsForMergerRelatedCosts`	$376.37K	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$-431.23K	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$-462.41K	USD	3 Qtrs
LOSS FROM OPERATIONS	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-444.91K	USD	3 Qtrs
LOSS FROM OPERATIONS	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-413.73K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-413.73K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-444.91K	USD	3 Qtrs
LOSS PER COMMON SHARE	`EarningsPerShareBasicAndDiluted`	$-0.03	USD	1 Quarter
LOSS PER COMMON SHARE	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	3 Qtrs
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	13.30M	shares	1 Quarter
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	11.21M	shares	3 Qtrs

Cash Flow Statement 20 line items

Line Item	Tag	Value	Unit	Period
Net loss for the period	`NetIncomeLoss`	$-413.73K	USD	1 Quarter
Net loss for the period	`NetIncomeLoss`	$-444.91K	USD	3 Qtrs
Cost of reverse merger	`PaymentsForMergerRelatedCosts`	$376.37K	USD	3 Qtrs
Cost of reverse merger	`PaymentsForMergerRelatedCosts`	$376.37K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-10.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-2.26K	USD	3 Qtrs
Due to related party	`IncreaseDecreaseInDueFromRelatedParties`	$12.75K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-68.06K	USD	3 Qtrs
Increase in cash held in trust account	`IncreaseInCashHeldInTrustAccount`	$-25.00K	USD	3 Qtrs
Cash used in reverse merger	`NoncashMergerRelatedCosts`	$-325.00K	USD	3 Qtrs
Investment	`InvestmentIncomeInvestmentExpense`	$-50.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-400.00K	USD	3 Qtrs
Issuance of common stock for cash	`ProceedsFromIssuanceOfCommonStock`	$740.10K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$740.10K	USD	3 Qtrs
NET CHANGE IN CASH	`CashPeriodIncreaseDecrease`	$272.05K	USD	3 Qtrs
CASH, BEGINNING OF PERIOD	`Cash`	-	USD	Point-in-time
CASH, BEGINNING OF PERIOD	`Cash`	$272.05K	USD	Point-in-time
CASH, END OF PERIOD	`Cash`	-	USD	Point-in-time
CASH, END OF PERIOD	`Cash`	$272.05K	USD	Point-in-time
Liabilities assumed in the reverse merger	`LiabilitiesAssumedInReverseMerger`	$51.37K	USD	3 Qtrs

Stockholders Equity 9 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, Amount	`StockholdersEquity`	$287.01K	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquity`	$-8.18K	USD	Point-in-time
Payment received from stock subscription	`PaymentReceivedFromStockSubscription`	$101.00	USD	3 Qtrs
Issuance of shares upon reverse merger, Amount	`StockIssuedDuringPeriodValueOther`	-	USD	3 Qtrs
Issuance of comon stock for cash, Amount	`IssuanceOfComonStockForCashAmount`	$740.00K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-413.73K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-444.91K	USD	3 Qtrs
Ending Balance, Amount	`StockholdersEquity`	$287.01K	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquity`	$-8.18K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.